Multilocus parasite gene polymorphism and/or parasite-selected mutations in host genome may discriminate between relapse and reinfection in the failure of miltefosine treatment in visceral leishmaniasis.
Department of Microbiology, All-India Institute of Medical Sciences, Phulwarisharif, Patna, India.
Sushmita
S
Das
D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D010767:Phosphorylcholine / Q000031:analogs & derivatives*
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine